Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients

被引：2
|
作者：
Bargiel, Andrzej [1 ,2 ]
Obojski, Andrzej [3 ]
机构：
[1] Wroclaw Med Univ, Dept Internal Med Geriatr & Allergol, Wroclaw, Poland
[2] Wroclaw Med Univ, Students Sci Assoc, Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Internal Med & Allergol, Wroclaw, Poland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
COPD; -; management; Treatments;
D O I：
10.1183/13993003.congress-2015.PA3939
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3939
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD
    Fromer, L.
    Cooper, C. B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (08) : 1219 - 1236
  • [2] Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines
    Bartoli, Maria Laura
    Costa, Francesco
    Malagrino, Laura
    Nieri, Dario
    Antonelli, Sandra
    Decusatis, Giovanna
    De Simone, Claudia
    Santerini, Sabrina
    Cianchetti, Silvana
    Latorre, Manuela
    Vagaggini, Barbara
    Paggiaro, Pierluigi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (03) : 978 - 980
  • [3] The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D
    Kerstjens, Huib A. M.
    Deslee, Gaetan
    Dahl, Ronald
    Donohue, James F.
    Young, David
    Lawrence, David
    Kornmann, Oliver
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 32 : 101 - 108
  • [4] Impact of changing GOLD guidelines (2007-2011-2017) on assignment of a COPD patient to disease severity category
    Nowak, Marcin
    Brozek, Grzegorz M.
    Zejda, Jan E.
    Jankowski, Mateusz
    Pierzchala, Wtadyslaw
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (02): : 221 - 228
  • [5] Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011
    Vyshnyvetskyy, Ivan
    Mostovoy, Yuriy
    Onyshchenko, Olexiy
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [6] ECONOMIC IMPACT OF NON-ADHERENCE TO GOLD GUIDELINES IN COPD PATIENTS IN PRIMARY CARE IN SPAIN
    Galera, J.
    Lahoz, R.
    Lleonart, M.
    Riera, M.
    Sicras-Mainar, A.
    Miravitlles, M.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A320 - A321
  • [7] Guidelines for the Pharmacologic Treatment of COPD 2023: Canada versus GOLD
    Suissa, Samy
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [8] The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients
    Moreira, Susana
    Oliveira, Catia
    Escaleira, Dina
    Staats, Richard
    Valenca, Joao
    Barros, Andre
    Barbara, Cristina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [9] Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
    Grewe, Fabian A.
    Sievi, Noriane A.
    Bradicich, Matteo
    Roeder, Maurice
    Brack, Thomas
    Brutsche, Martin H.
    Frey, Martin
    Irani, Sarosh
    Leuppi, Joerg D.
    Thurnheer, Robert
    Clarenbach, Christian F.
    Kohler, Malcolm
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 627 - 635
  • [10] Consequences of Changing the GOLD Reports (2007-2011-2017) on the Treatment Regimen of Patients with COPD
    Brozek, Grzegorz Marek
    Nowak, Marcin
    Zejda, Jan Eugeniusz
    Jankowski, Mateusz
    Lawson, Joshua
    Pierzchala, Wladyslaw
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 16 (02) : 126 - 132
12345